HROW: Harrow, Inc.
Performance
HROW -19.04%
Watchlist
Select an item
Summary
HROW at a glance
HROW returned -19.04% over the past year and +18.22% a year over five years. Its worst drop in that year was -52.48%, smaller than 20% of stocks on Redstone, and its Sharpe ratio of -0.06 beats 25% of stocks on Redstone. It pays no dividends.
Current Drawdown
-49.87%
Rolling Volatility
52.80%
Actions
Metrics
Risk Indicators
Alpha-17.95%
Beta1.44x
Sharpe-0.06
Sortino-0.08
Omega0.99
Calmar-0.36
Martin-0.13
Profile
About HROW
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.0B
- Listed
- Apr 2007
- Employees
- 373
- Headquarters
- Nashville, TN
- Website
- harrow.com
Comparisons